Has Max Hale received payments from drug or device companies?

Yes. Drug and device makers reported $1,145 in general payments to Max Hale across 62 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Max Hale did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Max Hale come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Max Hale

Pediatrics · Birmingham, ALNPI 1609971613

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $983 of the $1,145 with a category attached, or 85.8%. It is spread thinly across 16 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations.

$1,145in general payments, 2019–2025

Across 62 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$246
Corium, LLC$215
Welch Allyn$162
Pfizer$109
Merck$95
Teva Pharmaceuticals USA, Inc.$88
plus $229 from 10 others

$1,319,498in research payments, 2019–2025

Across 409 payments — averaging $3226.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sanofi Pasteur Inc.$558K
Perrigo Company PLC$212K
Merck$140K
GSK$97K
Pfizer$94K
AstraZeneca$94K
plus $124K from 3 others

What the payments were for

Food & beverage$98386%
Gifts$16214%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	17	$246
Corium, LLC	12	$215
Welch Allyn	1	$162
Pfizer	5	$109
Merck	6	$95
Teva Pharmaceuticals USA, Inc.	7	$88
Seqirus USA Inc	2	$37
Tris Pharma Inc	2	$36
Supernus Pharmaceuticals, Inc.	2	$29
Shire North American Group Inc	2	$26
Sobi, Inc	1	$24
Arbor Pharmaceuticals, Inc.	1	$16
Vertical Pharmaceuticals, LLC	1	$16
Takeda Pharmaceuticals U.S.A., Inc.	1	$16
AstraZeneca	1	$16
Kaleo, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPOT Vision Screener$162

How this compares

$1,145 in reported general payments places this provider in the 80th percentile of 908 pediatrics providers in Alabama.

See all pediatrics providers in Alabama →

Other pediatrics in Birmingham

Tamera Coyne-BeasleyBirmingham$154K
Linda HammettBirmingham$123K
Darby McElderryBirmingham$111K
Audrey LloydBirmingham$40K
Suresh BoppanaBirmingham$31K
Sula GillespieBirmingham$19K
Brian StansellBirmingham$19K
Leslie PittsBirmingham$10K
Yolanda WheelerBirmingham$10K
Tanikqua MooreBirmingham$9K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →